The FDA announced on July 24, 2015, that Boehringer Ingelheim Roxane Inc voluntarily recalled Combivent Respimat Inhalation Spray due to a defective delivery system. The hazard involves inhalers emitting no spray or a short transient spray instead of the proper dose.
How to tell if you have it
- Brand: Combivent Respimat
- Product: Combivent Respimat Inhalation Spray, 20 mcg/100 mcg per actuation*, 4 Grams, 120 Metered Doses
- NDC: 0597-0024-02
- Lot #: 408267, Exp 11/17
- Distribution: Nationwide and Puerto Rico
The hazard
The recalled inhalers have a defective delivery system that causes them to spray improperly. This defect results in the device emitting either no spray or only a short transient spray.
Context
GovInfoNow's records show Boehringer Ingelheim Roxane Inc has 12 other recalls on record since 2012-11-05. Other recent recalls of similar products include Apotex Desmopressin Nasal Spray Recall (2026-04-08), ANI Pharmaceuticals Recalls Estradiol Gel (2026-05-12), and Synjardy XR Tablets Recall (2026-06-12).